1. 217 DEFINING LIKELIHOOD OF FUTURE RESPONSE IN PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH LENALIDOMIDE. Issue 1 (April 2015) Authors: Gerds, A.T.; List, A.F.; Giagounidis, A.; Hellström-Lindberg, E.; Li, J. Shiansong; Swern, A.S.; Sugrue, M.M.; Fenaux, P.; Sekeres, M.A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Current Diagnosis Patterns for Acute Myeloid Leukemia: Concordance Between Clinical Practice (Connect® Disease Registry) and Who 2008 Recommendations. (April 2017) Authors: George, T.I.; Erba, H.P.; Pollyea, D.A.; Abedi, M.; Roboz, G.J.; Thompson, M.A.; Fliss, A.; Swern, A.S.; Nifenecker, M.; Kiselev, P.; Sugrue, M.M.; Foucar, K. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of Lenalidomide Exposure on Response and Outcomes in Patients with Lower-Risk Non-Del(5Q) Myelodysplastic Syndromes (MDS). (April 2017) Authors: Garcia-Manero, G.; Santini, V.; Almeida, A.; Fenaux, P.; Gattermann, N.; Ozawa, K.; Goldberg, S.L.; Weaver, J.; Sugrue, M.M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Undertreatment of Patients with Myelodysplastic Syndromes (MDS): Analysis of an Electronic Medical Records (EMR) Database Cohort of US MDS Patients. (April 2017) Authors: Steensma, D.P.; Scott, B.L.; Ma, X.; Fliss, A.; Kiselev, P.; Swern, A.S.; Sugrue, M.M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗